Arrowhead Pharmaceuticals Inc (ARWR) — Financial Flexibility Index
Arrowhead Pharmaceuticals Inc (ARWR) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of $27.98 Million (operating CF $20.49 Million minus capex $7.49 Million) represents 0% of total liabilities ($881.88 Million). Also explore Arrowhead Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arrowhead Pharmaceuticals Inc Financial Flexibility Index (1997–2025)
Historical Financial Flexibility Index trend for Arrowhead Pharmaceuticals Inc across 29 annual periods. Check how strategically is Arrowhead Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Arrowhead Pharmaceuticals Inc (1997–2025)
Year-by-year free cash flow to debt coverage for Arrowhead Pharmaceuticals Inc. For the full company profile including market capitalisation, see Arrowhead Pharmaceuticals Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | $202.22 Million | $179.55 Million | $947.02 Million | ▲ +163.0% |
| 2024 | -0.34x | $-321.38 Million | $-462.85 Million | $948.74 Million | ▼ -809.3% |
| 2023 | 0.05x | $22.85 Million | $-153.89 Million | $478.39 Million | ▲ +115.7% |
| 2022 | -0.30x | $-83.35 Million | $-136.13 Million | $273.60 Million | ▼ -147.1% |
| 2021 | 0.65x | $194.79 Million | $171.22 Million | $301.33 Million | ▲ +147.0% |
| 2020 | -1.37x | $-83.44 Million | $-95.39 Million | $60.72 Million | ▼ -178.6% |
| 2019 | 1.75x | $185.04 Million | $173.03 Million | $105.81 Million | ▲ +162.5% |
| 2018 | -2.80x | $-45.80 Million | $-47.22 Million | $16.37 Million | ▼ -304.4% |
| 2017 | -0.69x | $-16.02 Million | $-23.94 Million | $23.16 Million | ▲ +62.1% |
| 2016 | -1.83x | $-60.57 Million | $-64.43 Million | $33.15 Million | ▲ +35.1% |
| 2015 | -2.81x | $-63.74 Million | $-65.71 Million | $22.65 Million | ▼ -40.6% |
| 2014 | -2.00x | $-33.70 Million | $-35.42 Million | $16.83 Million | ▼ -23.9% |
| 2013 | -1.62x | $-18.74 Million | $-19.03 Million | $11.59 Million | ▲ +16.1% |
| 2012 | -1.93x | $-14.86 Million | $-15.34 Million | $7.72 Million | ▼ -18.9% |
| 2011 | -1.62x | $-5.38 Million | $-5.39 Million | $3.32 Million | ▲ +10.0% |
| 2010 | -1.80x | $-7.69 Million | $-7.70 Million | $4.28 Million | ▲ +66.4% |
| 2009 | -5.36x | $-15.24 Million | $-15.28 Million | $2.84 Million | ▲ +1.4% |
| 2008 | -5.43x | $-26.90 Million | $-27.58 Million | $4.95 Million | ▲ +20.2% |
| 2007 | -6.80x | $-23.11 Million | $-23.87 Million | $3.40 Million | ▼ -43.4% |
| 2006 | -4.75x | $-13.86 Million | $-14.79 Million | $2.92 Million | ▲ +42.3% |
| 2005 | -8.23x | $-8.43 Million | $-9.10 Million | $1.02 Million | ▼ -244.2% |
| 2004 | -2.39x | $-1.65 Million | $-2.31 Million | $689.70K | ▼ -47.9% |
| 2003 | -1.62x | $-155.48K | $-157.60K | $96.18K | ▼ -2405.5% |
| 2002 | -0.06x | $-104.16K | $-105.83K | $1.61 Million | ▼ -6.5% |
| 2001 | -0.06x | $-81.81K | $-81.81K | $1.35 Million | ▲ +8.8% |
| 2000 | -0.07x | $-79.34K | $-80.09K | $1.19 Million | ▼ -103.4% |
| 1999 | -0.03x | $-35.22K | $-35.22K | $1.08 Million | ▼ -92.0% |
| 1998 | -0.02x | $-46.15K | $-46.15K | $2.71 Million | ▼ -1100.9% |
| 1997 | 0.00x | $4.56K | $4.56K | $2.68 Million | — |